Fundz

Krystal Biotech, Inc. reported raising $11.3 Million in an initial SEC Form D filing, from an offering of $11.3 Million

PUBLIC · KRYSAug 18, 2017

Amount Raised

$11.3 Million

$11.3 Million sold, per SEC Form D (first sale Aug 18, 2017)

Round Type

Venture

PittsburghBiotechnologyHealth CareTherapeutics

Quick answer

Krystal Biotech, Inc. raised $11.3 Million in a funding round, dated August 18, 2017. Krystal Biotech, Inc. is based in Pittsburgh, Pennsylvania, United States.

How much did Krystal Biotech, Inc. raise?
Krystal Biotech, Inc. raised $11.3 Million in a funding round on August 18, 2017.
What does Krystal Biotech, Inc. do?
Krystal Biotech, Inc. is a biotechnology company incorporated in Delaware, focusing on developing innovative therapies for patients with rare and debilitating diseases.
Where is Krystal Biotech, Inc. based and how big is it?
Krystal Biotech, Inc. is based in Pittsburgh, Pennsylvania, United States.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Krystal Biotech, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Pulse Biosciences, Inc. raised $30M on September 28, 2017.
  • Alcresta Therapeutics raised $10M on September 25, 2017.
  • Theriva Biologics raised $12M on September 13, 2017.
  • Azora Therapeutics, Inc. (DE) raised $40K on August 31, 2017.
  • DTx Pharma, Inc. raised $25K (Pre-Seed) on August 30, 2017.
  • VistaGen raised $1M on August 22, 2017.

Who to call at Krystal Biotech, Inc., and when

A new round usually means Krystal Biotech, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Krystal Biotech, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Krystal Biotech, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Krystal Biotech, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Krystal Biotech, Inc.

Location

2100 WHARTON STREET

Pittsburgh, Pennsylvania, United States

About

Krystal Biotech, Inc. is a biotechnology company incorporated in Delaware, focusing on developing innovative therapies for patients with rare and debilitating diseases. The company specializes in gene therapy, leveraging its proprietary platform to create genetically-encoded medicines. Key products and services include their lead product candidates targeting a range of dermatological conditions and genetic disorders. Krystal Biotech primarily serves healthcare markets in the United States, with ongoing clinical trials that suggest a significant emphasis on advancing its therapeutic pipeline. The company operates in a rapidly evolving field, indicating potential for impactful growth and collaboration within the biopharmaceutical industry.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Krystal Biotech, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Krystal Biotech, Inc.'s next move

See what Strategic adds

Krystal Biotech, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.